Strains & genetics
Exploration of cannabis strains, seed lines, and genetic candidates for authorised cultivation programmes.
New Zealand • authorised industry partners only
Haze Pharmaceuticals works with authorised medicinal cannabis partners to explore genetics, evaluate phenotype expression, and support seed-led cultivation in licensed environments.
Industry information only. Not patient advice, product advertising, or a public sales channel.
What we focus on
Haze is focused on the practical early cultivation work that helps authorised partners identify promising genetics before wider production decisions are made.
Genetics & pheno hunting
Start with candidate seed lines, grow under defined conditions, observe expression, and narrow the pool to genetics that fit the authorised partner's goals.
Exploration of cannabis strains, seed lines, and genetic candidates for authorised cultivation programmes.
Observe plant expression, structure, consistency, aroma characteristics, resilience, and cultivation fit.
Selection can be guided by analytical and aromatic profile targets agreed with authorised partners.
Support for seed-focused cultivation cycles, harvest-stage planning, and partner handover.
Licensed cultivation environments
Haze is positioned for B2B collaboration with licensed or otherwise authorised medicinal cannabis organisations working through appropriate licence conditions.
Agree genetics, cultivation constraints, and selection priorities before work begins.
Evaluate candidate expression in controlled cultivation conditions with partner-defined criteria.
Shortlist lines for the next seed or cultivation cycle, without therapeutic or consumer-effect claims.
Authorised partners only
Partner enquiry
If you represent a licensed or authorised medicinal cannabis operator and want to discuss genetics, pheno hunting, terpene-profile selection, or seed-harvest programmes, contact the Haze team.
Haze cannot respond to patient, prescription, product availability, pricing, or public purchase enquiries.